Vera Maslova

#EPeeps how can we recognize,if the potential in LSPV is LAA farfield,or a signal from PV?Look at the separation of potentials during distal CS pacing! @evgeny_lyan @ThomasDemming #fellowsfirst #CardioTwitter #FOAMed

🎙️ New episode of EHRA CardioTalk is out! @WoDoehner joins hosts @simovicst & @JacopoImberti to discuss: • What #AFib burden truly represents in the era of continuous monitoring • Its link with stroke risk and outcomes • Whether #AFib burden should influence anticoagulation and rhythm control strategies 🎧 Stay tuned for the episode! 🔗bit.ly/47kQBLO

📢 #EHRA26 Late-Breaking Clinical Science revealed! ✨ Join us in Paris 🇫🇷 12–14 April 2026 for a top-tier Late-Breaking Clinical Science sessions with landmark trial results & practice-shaping data. 📖 Explore the scientific programme and Late-breaking clinical science bit.ly/4si6Np8 👉 Secure your place today: bit.ly/4sdGWie @purerfellner @HaranBurri @SergeBoveda @SteliosTzeis @CardioOnline

@EPWaveDoc Great case, Andreas! Could you show the sinus node map? How have you defined the „borders“ of sinus node?

Interesting case of a difficult-to-induce ectopic atrial tachycardia in young woman presenting with palpitations. Successful ablation 5 mm from the sinus node #Epeeps

🚨New #OpenAccess Article in @JICE_EP Bipolar Radiofrequency Ablation for Refractory Scar-Related Interatrial Septal Tachycardias: a Multicenter Study 🧐📖doi.org/10.1007/s10840… by @ftrae, Łukasz Zarębski, @Dr_LohitG, Sanghamitra Mohanty, @vincenzomirco93, Prem Geeta Torlapati, Francis E. Marchlinski, @natale_md & @Dr_Santangeli #EPeeps

💊Which anti arrhythmic drug (AAD) can be responsible for this arrhythmia?💉 Don’t miss the upcoming #EHRA #Webinar: What every clinician should know about antiarrhythmic drugs 📅 9 September 2025 🕑 18:00 to 19:00 CEST 🌐 esc365.escardio.org/event/2088 @EHRAPresident @ESC_Journals

HOTLINE 🔥in #ESCCongress2025 Personalized Digital Twin guided ablation ⬇️AFib recurrence in persistent AF! 🇰🇷 CUVIA-PRR RCT at #ESCCongress Knowledge-driven Digital Twin approach 📊 1y recurrence-free: 68% with PVI only vs 80.6% with PVI + Digital Twin

Piere Jais 🇫🇷on BEAT AF at #ESCCongress ⚡️ PFA vs 🔥 RF in paroxysmal AF 👥 292 pts, RCT, 9 EU centers 📊 No difference in AF recurrence at 12 mo ➡️ PFA is as effective as RF ablation in paroxysmal AF

🔥HOTLINE #ESCCongress ALONE Trial: OAC after AF ablation? 👥 840 pts w/o AF recurrence in 12 months randomized: OAC vs no OAC 📊 Primary endpoint (stroke, embolism, bleeding) lower in no OAC (2.2%vs 0.3 p=0.2) 🩸 Difference mainly from↓major bleeding ⚡️Ischemic events:similar

Don’t miss the Great Debates on Conduction System Pacing with Christophe Lecqlerc @NinaBecher8 @LinaMarcantoni Jens Cosedis Nilsen @HaranBurri @OCanoPerez & Fritz Prinzen 📅 08:15-09:00 📌 Damascus #ESCCongress #EHRA_ESC @EHRAPresident

Wonderful ending of day 2 in #ESC2025 with VA treatment in CMP! @GerdHindricks @KatjaZeppenfeld and @GiovanniPeretto gave us an overview of aetiology relevance and impact in therapeutical strategies in patients with NSVTs, LVCMP and inflammatory LVCMP 👏 👏 👏 @escardio

VT session at #ESCCongress chaired by @AndreaSarkozy & @Petr_Peichl @GerdHindricks on non-sustained VT in device pts: 📉 Knowledge gaps, no RCTs 📊 No ↑ mortality evidence 🫀 Evaluate structural disease 😷 Treat based on symptoms 🤝 Define & share goals with patient

#ESCCongress 🇪🇸 AI to improve management of cardiac arrhythmias 👉”Patient is not only a left atrial size” - substrate, triggers, comorbidities, biomarkers and clinical environment are crucial components that must be integrated into AI models 👉 Dynamic and multimodal ML significantly enhances prediction models by capturing the complex, evolving nature of cardiac arrhythmias 👉 Implementing AI models in the right patient population—and accurately identifying that population—is essential for maximizing their clinical impact 👉 The sequence of comorbidities is crucial for disease progression, and AI should assess its impact to improve personalized care

ECG Quiz now by the #ESCCongress! With @AndreaSarkozy @Phiso_de @BoldiKovacsMD @ManningerMartin @DrYanushiDW @simovicst @GawalkoMonika @Dominik_Linz @PriyaPBK

@purerfellner @EHRAPresident on ablation in persistent #AFib ✅ Only PVI is recommended ❓Low-voltage guided and posterior wall ablation remains area of uncertainty ❓PFA is safer, but still no hard evidence on better outcomes 🚨WITHDRAW-AF trial showing withdrawal of #HF medication in patients undergone #AFib ablation may be considered #ESCCongress2025

#ESCCongress 🇪🇸 @WFMMD presenting data from PRAETORIAN/ATLAS: Inappropriate shock with S-ICD vs. transvenous ICD 👉673 (S-ICD) vs 669 (T-ICD) patients 👉higher incidence of 1st inappropriate shock in S-ICD VS T-ICD (HR 1.61) due to cardiac oversensing or electromagnetic interference 👉T-ICD more likely to cause 1st inappropriate shock due to atrial arrhtthmia

VICTOR study 🤓 Vericiguat in HFrEF: no difference with placebo in reduce composite CV death or HHF @escardio #ESC75Years #CVHealthForAll #LetsRise2025 #ESCCongress @ACVCPresident @PabloJ @drdargaray @drmilicaa @RThachilMD @Hragy @HannahSchaubro1 @rafavidalperez @veramasloo

#ESC2025 alle #Youngs – kommt vorbei, nicht verpassen! 📅 30. & 31.08., ab 12 Uhr 📍 DGK-Stand Nr. 14, Halle 10 👥 Meet & Greet mit Stefan Blankenberg, @thiele_holger , Norbert Frey

3) CAAN-AF on CRT-D patients with permanent AF ➡️ AVN ablation vs drug therapy showing no difference 🚨 in HF mortality and HF events 🇦🇺 4) Analysis of PRAETORIAN and ATLAS populations on an ⬆️ of inappropriate shocks on S-ICD vs TV-ICD!! 🇨🇦🇳🇱

Outstanding Late Breaking session on advances in CIED 👏👏 1) Treebard registry showing ↗️ in CV mortality and HF hospitalization with LBBP vs RVP 🇮🇹 2) PhysioSync HF showing LBBP showing inferiority ⬇️‼️vs CRT-P in HFrEF (85% NICM) 🇧🇷 More in the thread 👇 @escardio

📢 #LateBreakingTrial @ESCCongress2025 LBBAP vs RVP in young adults – Italian registry 🇮🇹 👥 4911 screened | 344 <65y ⏱ 2-year FU ✅ LBBAP ↓ CV mortality + HF hosp. ➡️ Strongest benefit in young pts with AV block @escardio @simovicst @GawalkoMonika @PriyaPBK @Dominik_Linz